TY - ABST
T1 - Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial
AU - Jerkeman, Mats
AU - Kolstad, Arne
AU - Hutchings, Martin
AU - Pasanen, Annika
AU - Meriranta, Leo
AU - Niemann, Carsten Utoft
AU - Jorgensen, Rasmus Rask Kragh
AU - El-Galaly, Tarec Christoffer Christoffer
AU - Riise, Jon
AU - Leppä , Sirpa
AU - Christensen, Jacob Haaber
AU - Wader, Karin Fahl
AU - Glimelius, Ingrid
N1 - Abstract No. 623
PY - 2022/11/15
Y1 - 2022/11/15
U2 - 10.1182/blood-2022-155654
DO - 10.1182/blood-2022-155654
M3 - Conference abstract in journal
SN - 0006-4971
VL - 140
SP - 184
EP - 185
JO - Blood
JF - Blood
IS - Suppl. 1
M1 - 623
T2 - 64th ASH Annual Meeting & Exposition
Y2 - 10 December 2022 through 13 December 2022
ER -